<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01103167</url>
  </required_header>
  <id_info>
    <org_study_id>korea_bcm_hd</org_study_id>
    <nct_id>NCT01103167</nct_id>
  </id_info>
  <brief_title>Body Composition Monitor in Hemodialysis Patients</brief_title>
  <official_title>The Association Between Body Composition and Biomarkers in Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gachon University Gil Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gachon University Gil Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Control of volume status is a pivotal issue in haemodialysis therapy. Objective and practical
      management for maintaining normovolemia is needed.

      The investigators hypothesized that intervention of volume status with the body composition
      monitor (BCM) may improved hemodynamic parameters and biomarkers in hemodialysis patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will assess BCM in enrolled hemodialysis patients by 4 weeks for 16 weeks
      During the former 8-week intervention period, The investigators will adjust patients' volume
      status according to the results of BCM.

      During the latter 8-week observational period, The investigators will evaluate the changes of
      patients' hemodynamic parameters and biomarkers.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">October 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood pressure</measure>
    <time_frame>up to 16 weeks</time_frame>
    <description>Systolic blood pressure, number of anti-hypertensive agents hypotensive episode</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>biomarkers</measure>
    <time_frame>up to 16 weeks</time_frame>
    <description>C-reactive protein, interleukin-6, MMP-1, leptin, resistin, adiponectin, VEGF</description>
  </secondary_outcome>
  <enrollment type="Anticipated">160</enrollment>
  <condition>End Stage Renal Disease</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>control of ultrafiltration</intervention_name>
    <description>During the interventional period, dry weight of patients will be adjusted according to the results of body composition.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  6-month or more stable hemodialysis patients

          -  18 years or more

          -  less than 5% of changes of dry weight for last 3 months

        Exclusion Criteria:

          -  pregnancy

          -  active malignancy

          -  cardiac pacemaker or defibrillator

          -  history of extremity amputation

          -  active infectious disease within 3 months

          -  admission history for complication related to hemodialysis within 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sejoong Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gachon University Gil Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sejoong Kim, MD, PhD</last_name>
    <phone>82-32-460-8305</phone>
    <email>imsejoong@hanmail.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kwon Wook Joo, MD, PhD</last_name>
    <phone>82-2-2072-1964</phone>
    <email>junephro@paran.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sejoong Kim</name>
      <address>
        <city>Incheon</city>
        <zip>405-760</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sejoong Kim, MD, PhD</last_name>
      <phone>82-32-460-8305</phone>
      <email>imsejoong@hanmail.net</email>
    </contact>
    <contact_backup>
      <last_name>Kwon Wook Joo, MD, PhD</last_name>
      <phone>82-2-2072-1964</phone>
      <email>junephro@paran.com</email>
    </contact_backup>
    <investigator>
      <last_name>Kwon Wook Joo, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ho Jun Chin, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2010</study_first_submitted>
  <study_first_submitted_qc>April 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2010</study_first_posted>
  <last_update_submitted>April 13, 2010</last_update_submitted>
  <last_update_submitted_qc>April 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Gachon University Gil Medical Center IRB</name_title>
    <organization>Gachon University Gil Medical Center</organization>
  </responsible_party>
  <keyword>body composition</keyword>
  <keyword>blood pressure</keyword>
  <keyword>hemodialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>October 1, 2011</submitted>
    <returned>November 4, 2011</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

